David A. Scheinberg

David A. Scheinberg
EducationCornell University BA Johns Hopkins University School of Medicine MD, PhD
Medical career
ProfessionPhysician-scientist
InstitutionsMemorial Sloan Kettering Cancer Center
Weill Cornell Medicine
Sub-specialtiesLeukemia

David A. Scheinberg is an American physician, scientist, drug developer, and entrepreneur, who is Vincent Astor Chair, Chair of the Center for Experimental Therapeutics and former Chair of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK).[1] He is a pioneer and inventor of targeted alpha particle therapies and alpha particle generators for use in patients with cancer.[2][3]

  1. ^ "At Work: Center for Experimental Therapeutics Chair David Scheinberg | Memorial Sloan Kettering Cancer Center". www.mskcc.org.
  2. ^ Scheinberg, D. A.; Strand, M.; Gansow, O. A. (1982-03-19). "Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies". Science. 215 (4539): 1511–1513. Bibcode:1982Sci...215.1511S. doi:10.1126/science.7199757. ISSN 0036-8075. PMID 7199757.
  3. ^ McDevitt, Michael R.; Ma, Dangshe; Lai, Lawrence T.; Simon, Jim; Borchardt, Paul; Frank, R. Keith; Wu, Karen; Pellegrini, Virginia; Curcio, Michael J. (2001-11-16). "Tumor Therapy with Targeted Atomic Nanogenerators". Science. 294 (5546): 1537–1540. Bibcode:2001Sci...294.1537M. doi:10.1126/science.1064126. ISSN 0036-8075. PMID 11711678. S2CID 11782419.